![N,1,4,4-tetramethyl-8-(4-(4-methylpiperazin-1-yl)phenylamino)-4,5-dihydro-1H-pyrazolo[4,3-h]Quinazoline-3-carboxamide](https://static.cymitquimica.com/products/3D/img/FT40655.png "Click to enlarge")
N,1,4,4-tetramethyl-8-(4-(4-methylpiperazin-1-yl)phenylamino)-4,5-dihydro-1H-pyrazolo[4,3-h]Quinazoline-3-carboxamide
CAS: 802539-81-7
Ref. 3D-FT40655
| 5mg | To inquire | |
| 10mg | To inquire | |
| 25mg | To inquire | |
| 50mg | To inquire | |
| 100mg | To inquire |
Product Information
Palbociclib is a drug that inhibits the activity of the cyclin-dependent kinase inhibitors (CDKIs) CDK4 and CDK6. It prevents their phosphorylation, which in turn prevents cells from progressing through the cell cycle. Palbociclib has been shown to be effective against a number of cancers including brain cancer, breast cancer, and ovarian cancer. Palbociclib is not active against non-malignant cells or cells that have already progressed through the cell cycle, such as thymoma cells. The LC-MS/MS method can be used to measure palbociclib levels in plasma and serum samples.
Chemical properties
Technical inquiry about: 3D-FT40655 N,1,4,4-tetramethyl-8-(4-(4-methylpiperazin-1-yl)phenylamino)-4,5-dihydro-1H-pyrazolo[4,3-h]Quinazoline-3-carboxamide
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
